{
  "id": 19190595,
  "title": "Bulevirtide Linked to Less Decompensation in Chronic Hep D With Cirrhosis",
  "url": "https://urgent.news/2026/11/09/bulevirtide-linked-to-less-decompensation-in-chronic-hep-d-with",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-09T17:54:02.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/aasld/123789"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- In patients with chronic hepatitis delta (CHD) with cirrhosis, treatment with bulevirtide (Hepcludex) was associated with lower risk of liver decompensation, according to results from a European retrospective study. Among more...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}